Zoetis AI Adoption Tracker
Last updated: August 9, 2026
Overview
Zoetis, the world's leading animal health company, has established itself as a pioneer in AI-powered veterinary diagnostics and data-driven innovation [1]. The company's flagship AI product, Vetscan Imagyst, represents the first and only veterinary AI analyzer offering seven distinct testing capabilities including AI Fecal, AI Urine Sediment, AI Dermatology, AI Blood Smear, AI Equine Fecal Egg Count, AI Masses, and Digital Cytology [2]. Beyond diagnostics, Zoetis is leveraging AI across its entire biopharma value chain, from drug discovery and clinical development to manufacturing and commercial operations [3]. With over $650 million invested in R&D annually and a comprehensive digital transformation strategy, the company is positioning itself to lead the next era of animal health innovation in a market projected to reach $90 billion by 2035 [4].
- [1] AI-Powered Vetscan Imagyst - Zoetis Diagnostics
- [2] Validation of Vetscan Imagyst®, a diagnostic test utilizing an artificial intelligence deep learning algorithm
- [3] Transforming drug discovery and development with generative AI
- [4] People who use AI will replace those who don't, Zoetis executive says
AI Maturity Index
Radar Comparison
Peer Comparison: Zoetis vs healthcare
Based on 66 companies in sector
| Dimension | Zoetis | Sector Avg | Diff |
|---|---|---|---|
| Adoption | 4.0 | 3.7 | +0.3 |
| Proficiency | 4.0 | 3.5 | +0.5 |
| Impact | 4.0 | 3.6 | +0.4 |
| Overall | 4.0 | 3.6 | +0.4 |
AI Hiring Signals
Zoetis Job Postings Analysis
Tech vs Non-Tech AI Requirements
Top Departments by AI Mention Rate
Analysis
AI skills are increasingly expected across Zoetis, with 10.5% of all job postings mentioning AI. While tech roles lead at 20.7%, non-tech roles show moderate AI requirements at 7.1%, particularly in Sales and Legal departments, indicating broader organizational AI adoption.
View Sample Job Postings (8 sources)
Key Metrics
AI Initiatives
Infosys Strategic Collaboration
June 24, 2025
Long-term partnership to enhance IT operations and digital capabilities
Integration of advanced AI solutions and automation services to improve operational efficiency and support digital transformation across the organization
AI Masses Capability
June 2, 2025
Latest AI-powered cytologic capability for Vetscan Imagyst platform
AI analysis of common lymph node and skin/subcutaneous masses, delivering fast, accurate screening of potentially neoplastic cells in minutes
AI-Driven Drug Discovery Platform
2025
AI and generative tools for accelerating drug discovery and development
Using Biograph AI-powered tool and massive datasets to identify potential new drug targets virtually, create models of animal immune systems, and predict therapeutic efficacy
Next Generation Sales Engine
2024
AI-powered sales optimization platform
Analyzes client consumption data to suggest tailored sales strategies and product recommendations, deployed in 15 countries with 5-9% sales improvement
Frequently Asked Questions
Vetscan Imagyst is the only commercially available veterinary AI analyzer offering seven distinct testing capabilities in one platform, providing point-of-care results in minutes with expert-level accuracy.
Zoetis uses AI tools like Biograph to analyze massive datasets, create virtual models of animal immune systems, and identify potential drug targets before physical testing, significantly reducing development time and costs.
Their AI-powered Next Generation Sales Engine has delivered 5-9% sales improvements in the 15 countries where it's deployed by analyzing client data to provide tailored recommendations.
The company uses a venture capital-style approach with 'explorer' teams, focuses on 'golden use cases,' and emphasizes colleague-to-colleague learning to build trust and drive adoption.
Zoetis aims to build an integrated, data-centric ecosystem around their 'Continuum of Care' framework, transforming from a product company to a data-powered organization leading the AI era in animal health.
In Application
| Application | Vendor | Use Case |
|---|---|---|
| Biograph | Third-party | AI-powered tool that integrates biodata into knowledge graphs to identify potential new drug targets and generate virtual efficacy scores |
| Microsoft Copilot | Microsoft | AI assistant for productivity and workflow optimization across the organization |
| ChatGPT | OpenAI | AI assistance for various business applications and workflow optimization |
| Google Cloud Vertex AI | AI and machine learning platform for model development and deployment |
Sources
AI-Powered Vetscan Imagyst - Zoetis Diagnostics
Validation of Vetscan Imagyst®, a diagnostic test utilizing an artificial intelligence deep learning algorithm
Transforming drug discovery and development with generative AI
People who use AI will replace those who don't, Zoetis executive says
Infosys Announces Strategic Collaboration with Zoetis to Enhance Digital Capabilities
Zoetis's AI Strategy: Analysis of Dominance in Animal Health AI
2023 Annual Report (10-K)
Related Companies
About AI Tracker
AI Tracker is a research project by Larridin, the AI execution intelligence platform.
Methodology: We analyze earnings calls, press releases, partnership announcements, and product documentation. All assessments are based solely on publicly available information—no private customer data is used.
Maturity Scoring: Each dimension is rated on a 4-tier scale (Nascent → Emerging → Scaling → Leading) based on evidence from public sources. Industry averages are computed as the median across all tracked companies in the sector.